Patients with chronic hepatitis and/or cirrhosis therefore form a high risk population which would benefit from regular screening for HCC by serial measurement of serum alpha-fetoprotein (AFP) levels and hepatic ultrasound (4, 5). Here, AFP is linked to hepatocellular carcinoma.